Europe’s medicines regulator said Monday that it could approve the first coronavirus vaccines late this year or early next, as it evaluates the most promising candidates. The clarification came after EU Commission president Ursula von der Leyen said last week…
Read More
How the regulator is regulated: Insight into immune-related protein holds therapeutic value
In immune-related disorders, therapy often involves identifying the molecules responsible for immune dysregulation and targeting them using drugs. This type of immune therapy is also used for cancer treatment, owing to the important role that immune cells play in cancer…
Read More